Moderna plans to invest about $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, it said on Thursday.
n the latest move by the pharmaceuticals industry to manufacture drugs on the continent, Moderna’s proposed site will also include bottling and packaging capabilities.
The vaccines will use Moderna’s mRNA technology, but the statement did not say if it would be the US company’s COVID-19 shot.
More to follow
Visit our Covid-19 vaccine dashboard for updates on the roll out of the vaccination program and the rate of Coronavirus cases Ireland